LXRX- Lexicon Pharmaceuticals, Inc.

Name: Lexicon Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Lexicon Pharmaceuticals, Inc. (LXRX) has 9 insiders with recent SEC Form 4 filings, including 115 buys and 2 sells. LXRX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Debbane Raymond	1.91M	$3.96M	-
CEO	Exton Michael	1.01M	$2.09M	-
CFO	Coiante Scott M	160.2K	$332.5K	-
VP	Granowitz Craig B	156.0K	$323.8K	-
VP	McDermott Wendy	149.3K	$309.9K	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 15, 2021	Tessmer James F	VP, Finance &Accounting	Sale+OE	22,912	$6.92	$158,439.72	-13.8%	-30.3%	-71.6%
Dec 16, 2020	Artal International S.c.a.47	Director, 10% Owner	Buy	10,937,500	$3.20	$35,000,000.00	+51.3%	-	-
Dec 16, 2020	Invus Public Equities, L.P.78	Director, 10% Owner	Buy	10,937,500	$3.20	$35,000,000.00	+51.3%	-	-
Sep 18, 2019	Coats Lonnel	President And CEO	Buy	50,000	$3.10	$155,000.00	+28.2%	-	-
Sep 18, 2019	Santini Alexander A	EVP And CCO	Buy	4,500	$3.36	$15,115.00	+14.6%	-	-
Sep 17, 2019	Coats Lonnel	President And CEO	Buy	50,000	$3.13	$156,403.06	+7.6%	-	-
Sep 16, 2019	Sobecki Christopher J	Director	Buy	25,000	$2.55	$63,717.59	+0.8%	-	-
Sep 16, 2019	Debbane Raymond75	Director	Buy	103,042	$2.69	$277,591.21	+1.8%	-	-
Sep 13, 2019	Debbane Raymond75	Director	Buy	197,473	$2.40	$474,759.80	+8.7%	-	-
Sep 13, 2019	Sobecki Christopher J	Director	Buy	99,249	$2.41	$238,750.09	+6.6%	-	-

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC